Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CACNA1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TTLL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGEM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TKFC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RGL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0226L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTLL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC19A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on